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SUMMARY
Hematopoietic potential arises in mammalian
embryos before adult-repopulating hematopoietic
stem cells (HSCs). At embryonic day 9.5 (E9.5), we
show the first murine definitive erythro-myeloid pro-
genitors (EMPs) have an immunophenotype distinct
from primitive hematopoietic progenitors, maturing
megakaryocytes and macrophages, and rare B cell
potential. EMPs emerge in the yolk sac with erythroid
and broad myeloid, but not lymphoid, potential.
EMPs migrate to the fetal liver and rapidly differen-
tiate, including production of circulating neutrophils
by E11.5. Although the surfacemarkers, transcription
factors, and lineage potential associated with EMPs
overlap with those found in adult definitive hemato-
poiesis, they are present in unique combinations or
proportions that result in a specialized definitive
embryonic progenitor. Furthermore, we find that em-
bryonic stem cell (ESC)-derived hematopoiesis reca-
pitulates early yolk sac hematopoiesis, including
primitive, EMP, and rare B cell potential. EMPs do
not have long-term potential when transplanted in
immunocompromised adults, but they can provide
transient adult-like RBC reconstitution.
INTRODUCTION
Hematopoiesis in the adult consists of multipotent hematopoiet-
ic stem cells (HSCs) that differentiate through increasingly
lineage-restricted progenitors that are modulated to provide a
plethora of mature blood cells. However, this paradigm does
not hold for the early embryo, which must simultaneously create
the hematopoietic system while meeting the demands of embry-
onic growth and tissue differentiation with expanding blood
cell numbers and lineage complexity. Additionally, hematopoiet-
ic function is required prior to the existence of HSCs in the
mammalian embryo (Fujiwara et al., 1996; Kumaravelu et al.,
2002; Mu¨ller et al., 1994), necessitating the emergence of alter-
nate sources of transient hematopoietic progenitors. The first
wave of embryonic hematopoiesis creates a cohort of circulating
‘‘primitive’’ red blood cells that mature semi-synchronously in
the bloodstream and can be distinguished from later fetal and
adult ‘‘definitive’’ erythroid cells by their large size and embryonic
globin expression (for review, see Palis, 2014). Primitive erythroid
cells are derived from a discrete wave of extraembryonic yolk
sac progenitors temporally associated with megakaryocyte
and macrophage potential (Palis et al., 1999; Tober et al.,
2007). However, evidence in the mouse demonstrates that
primitive hematopoiesis is not sufficient to support embryonic
survival until HSCs are functional (Chen et al., 2011). In the
mouse embryo, there is a second wave of yolk-sac-derived he-
matopoiesis that consists of definitive erythroid, megakaryocyte,
myeloid, and multipotent progenitors (Chen et al., 2011; Palis
et al., 1999, 2001). These definitive erythro-myeloid progenitors
(EMPs) are thought to be the source of the thousands of defini-
tive erythroid progenitors and precursors found in the murine
fetal liver prior to HSC colonization (Gomez Perdiguero et al.,
2015; for review, see Frame et al., 2013). Definitive erythroid pro-
genitors (BFU-Es) also first emerge in the yolk sac of human
embryos and then are found in the fetal liver before HSCs (for re-
view, see Frame et al., 2013). In zebrafish embryos, EMPs
emerge distinct from both primitive erythropoiesis and HSCs
(Bertrand et al., 2007). In the mouse, HSC-independent hemato-
poiesis is not only necessary but also sufficient to support sur-
vival until the birth of embryos lacking HSCs (Chen et al.,
2011). Rare cells with lymphoid potential also arise before
adult-transplantable HSCs, including HSC-independent B-1
cell progenitors and immature HSCs capable of becoming
HSCs after ex vivo culture or when transplanted into specialized
hosts (Arora et al., 2014; Kieusseian et al., 2012; Kobayashi et al.,
2014; Yoder et al., 1997). However, the relationship between
these cells and EMPs has not been resolved. The overlap in
spatial and temporal emergence as well as shared immunophe-
notypic markers has hampered distinguishing the origin and
contributions of these waves of embryonic hematopoiesis.
Here,we report an immunophenotype that distinguishes EMPs
frommaturing primitive erythroid cells,macrophages, andmega-
karyocytes, as well as early definitive hematopoietic progenitors
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with B cell or immature HSC potential. Utilizing this unique immu-
nophenotype, EMPs were shown to emerge in the yolk sac with
erythroid and broad myeloid potential, then migrate to the fetal
liver and rapidly differentiate, including the production of circu-
lating neutrophils by embryonic day 11.5 (E11.5). In adult hosts,
EMPs lack long-term potential but are able to provide transient
adult-like red blood cell (RBC) reconstitution. Furthermore, we
found that embryonic stem cell (ESC)-derived hematopoiesis
recapitulates early yolk sac HSC-independent hematopoiesis,
including distinct primitive, EMP, and rare B cell potential.
RESULTS
EMPs Acquire a Unique Immunophenotype as They
Emerge in the Yolk Sac
The emergence of hematopoietic progenitors in the yolk sac and
the aorta gonad mesonephros (AGM) of the mouse embryo has
been associated with kit+CD41+ cells (Ferkowicz et al., 2003;
Mikkola et al., 2003; Mitjavila-Garcia et al., 2002). The E7.5 neu-
ral plate mouse conceptus contains only primitive hematopoietic
progenitors (Palis et al., 1999) and lacks a distinct kithi population
(Figure 1A). By E8.5, concurrent with the appearance of the first
definitive hematopoietic colony-forming cells (CFCs), a small
population of kithiCD41+ cells is detected in the yolk sac. A sub-
set of E8.5 kithiCD41+ cells is also positive for CD16/32, an
antibody that recognizes the low-affinity FCgII/III receptors
(Figure 1A). Both CD16/32-positive and negative cell fractions
contain definitive hematopoietic CFC activity, as defined by
definitive erythroid or granulocyte potential, which is not con-
tained in the primitive wave of hematopoiesis (Figure 1B; Palis
et al., 1999). At E8.5, primitive erythroid CFCs were localized to
the kitloCD41lo population, while macrophage potential, a
component of both primitive and EMP hematopoietic waves,
was present in kitlo and kithi populations. By E9.5, the kit+CD41+
population increased to more than 1,000 cells per yolk sac, over
90% of which are CD16/32+ (Figure 1A). At E9.5, we found that
the erythroid, megakaryocyte, and myeloid CFCs, including
high-proliferative-potential progenitors (HPP-CFCs), were asso-
ciatedwith the kit+CD41+CD16/32+ population (Figure 1C). Thus,
definitive EMP potential arises at E8.25 as a kithiCD41+ popula-
tion and by E9.5 resides in a kithiCD41+CD16/32+ population.
E9.5 yolk sacs also contain hundreds of kit-negative cells
expressing either CD41 or CD16/32 (Figure 1D) that lack CFC
potential (Figure 1C) but express other cell-surface markers
consistent with maturing megakaryocytes (GP1bb+CD45) or
macrophages (F4/80+CD45+), respectively (Figure 1D). The line-
age markers GP1bb or F4/80 were not expressed on the kithi
EMPs. The presence of hundreds of maturing megakaryocytes
and macrophages at E9.5, when only a few EMPs are detected
1 day earlier, is consistent with their derivation from the hundreds
of primitive hematopoietic progenitors that emerge in the yolk
sac between E7.25 and E8.5. Taken together, our data indicate
that by E9.5, the murine yolk sac contains several distinct
populations of blood cells, which include maturing primitive
erythroblasts, megakaryocytes, and macrophages, as well as
an emerging population of definitive hematopoietic progenitors,
EMPs, identified by their concurrent surface expression of kit,
CD41, and CD16/32.
EMPs Emerge in the Yolk Sac
Definitive hematopoietic progenitors are found in the embryo
proper only after the onset of circulation (E8.25), and circula-
tion-deficient mouse embryos lack definitive CFC in the embryo
proper at E9.5 (Lux et al., 2008; Palis et al., 1999). However, other
vascular beds, including the forming placenta and vitelline and
umbilical vessels, have also been suggested as sites of early
hematopoietic progenitor emergence (de Bruijn et al., 2000; Gor-
don-Keylock et al., 2013). Therefore, we reassessed the spatial
and temporal emergence of EMPs in the total conceptus, using
the presence of primitive erythroblasts (EryP) to estimate the
contribution of yolk-sac-derived blood cells found circulating in
tissues (McGrath et al., 2003). At E9.5, immunophenotypic
EMPs were enriched in the yolk sac, but not in the placenta or
in extraembryonic vessels, compared to the embryo proper (Fig-
ure 1E). Additionally, EMPs emerged from cultured yolk sacs, but
not chorion, allantois, or embryo propers from pre-circulation
embryos (Figure 1F). Finally, immunophenotypic EMPs were
found exclusively in the yolk sacs of E9.5 Ncx1-null circulation-
deficient embryos (Figure 1G). Comparable numbers of EMPs,
normally distributed throughout the embryo, were concentrated
in the yolk sac of Ncx1-null embryos (Figure 1G). This suggests
that, unlike HSCs (North et al., 2009), EMP commitment is inde-
pendent of blood flow.We conclude that EMPs emerge predom-
inately, if not entirely, in the yolk sac.
EMP Emergence Is Associated with Markers of
Hemogenic Endothelium and a Subset of Markers
Expressed by HSCs
HSCs co-express endothelial markers and hematopoietic
markers as they emerge from hemogenic endothelium, and the
first definitive erythroid potential migrating into the yolk sac
arises from a hemogenic endothelial precursor (Huber et al.,
2004; for review, see Swiers et al., 2013). Likewise, E9.5
kit+CD41+ EMPs expressmultiple endothelial and hematopoietic
markers (Figure 1H). Unlike HSCs, EMPs express CD16/32 but
not Sca1 on their cell surface (Figure 1H) or at the transcript level
(data not shown). AA4.1, a marker of fetal liver HSCs (Petrenko
et al., 1999), is detected on a small proportion of E9.5 EMPs,
but this may be part of EMP’s endothelial marker expression.
Unlike in the fetal liver, AA4.1 is expressed by E9.5 yolk sac
endothelial cells (Ho et al., 2003), and themajority of AA4.1+ cells
in E9.5 yolk sacs are in the endothelial kitneg vascular endothelial
(VE)-cadherin+ population (88% ± 2% of AA4.1+ cells). Taken
together, our data indicate that EMPs share markers of hemo-
genic endothelial emergence with HSCs but can be distin-
guished by expression of CD16/32 and lack of Sca1 expression.
EMPs Rapidly Proliferate with Extensive Erythroid-
Myeloid Potential
When E9.5 kit+CD41+CD16/32+ cells were cultured in medium
that supports diverse myeloid potential (Arinobu et al., 2005),
they proliferated more rapidly than bone marrow hematopoietic
progenitors, increasing in number 10,000-fold in 6 days (Fig-
ure 2A). This proliferation was associated with rapid maturation,
as evidenced by loss of CFC activity and a large increase in he-
moglobin-containing erythroid cells as well as megakaryocytes
and myeloid cells visible by 4 days in culture (Figures 2B and
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Figure 1. EMPs Acquire a Distinct Cell-Surface Phenotype as They Emerge in the Yolk Sac
(A) Analysis of yolk sac or bone marrow cells for expression of kit, CD41, and CD16/32.
(B) Distribution of CFCs in sorted E8.5 yolk sac cells. Def-CFCs represent the sum of colonies containing definitive erythroid cells and/or granulocytes (BFU-E,
CFC-G, CFC-GM, or Emix).
(C) Hematopoietic potential of E9.5 yolk sac populations.
(D) Expression of megakaryocyte or macrophage surface markers on E9.5 yolk sac cells. kit+(black), kitCD16/32+ (blue), kit CD41+ (red) populations (top
graphs) were examined for maturation markers (bottom graphs). One example of three experiments with similar results is shown.
(E) Ratio of immunophenotypic EMPs versus circulating primitive erythroblasts in dissected E9.5 conceptuses. YS, yolk sac; EP, embryo proper; Pl, placenta; VV
and UV, vitelline and umbilical vessels.
(F) Increases in definitive CFC in explanted E8.5 tissues after 48 hr.
(G) Numbers of immunophenotypic EMPs in Ncx1-null versus heterozygotes or wild-type E9.5 tissues.
(H) Immunophenotype of kit+CD41+ E9.5 yolk sac cells. Gating of positive cells was determined using a fluorescence minus one plus isotype negative control
(FMO). In all graphs, the average of three to five experiments is plotted ±SEM.
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2C). By 7 days of culture, EMPs generated an extensive reper-
toire of cells withmyeloidmorphology (Figure 2D) that expressed
lineage-specific genes (Figure 2E), including macrophages, neu-
trophils, basophils, eosinophils, and mast cells. Interestingly,
EMPs exhibited a significantly different lineage bias compared
to bone marrow progenitors and generated more erythroid
than myeloid cells. Within the myeloid lineage, EMPs also pro-
duced a higher percentage of F4/80+ monocyte/macrophages,
particularly large F4/80hi macrophages, than GR-1hi granulo-
cytes (Figures 2F and S1).
Individual EMPs can generate both erythroid and myeloid
cells, as observed when E9.5 kit+CD41+CD16/32+ cells plated
in semi-solid media generated Emix colonies with erythroid
and myeloid cells (Figure 2G). Furthermore, analysis of progeny
from individual EMPs in liquid culture demonstrated that 17% ±
4% EMPs had both erythroid and myeloid potential (Figures 2H
and S2). EMPs express many transcription factors that regulate
hematopoietic lineage decisions in adults (Iwasaki et al., 2006;
Orkin and Zon, 2008) and do so at levels intermediate between
adult granulocyte-monocyte progenitors (GMPs) and megakar-
yocyte-erythroid progenitors (MEPs), consistent with the
observed erythroid and-myeloid potential of EMPs (Figure 2I).
High levels of Gata-1 and low expression of Gfi1 compared
with adult GMPs also correlate with the predilection of EMPs
to generate erythroblasts and macrophages.
EMPs Lack B Cell Potential
B cell potential independent of HSC formation has been identi-
fied in the E9.5 yolk sac coincident with EMP formation (Kobaya-
shi et al., 2014). However, EMPs lack IL7R and Flt3 cell-surface
markers and Pax5 transcription factor expression, which are
associated with lymphoid progenitors arising from HSCs (Fig-
ure 1H; data not shown; Adolfsson et al., 2005). Furthermore,
EMPs differentiated in vitro in IL7-containing media failed to ex-
press Rag2, unlike parallel cultures of adult lineagekit+ cells
(Figure 2E). Primary purified EMPs cultured on an OP9 cell
monolayer generated only myeloid and erythroid cells, whereas
IL7R+ bone marrow progenitors rapidly generated CD19+B220+
cells (Figures 3A and 3B). This short-term assay detects existing
lymphoid progenitors, while extended cultures on OP9 stroma
promotes emergence of lymphoid progenitors that then mature
into B cells. As reported previously (Yoshimoto et al., 2011),
extended cultures of unfractionated E9.5 yolk sac cells differen-
tiated at a low frequency into lymphoid progenitors by 12 days in
culture (Figure 3D) but only when subfractionated B cell potential
was present within the non-EMP fraction and absent in the EMP
population, indicating that B cell potential emerges indepen-
dently of EMPs in the E9.5 yolk sacs (Figures 3C and 3D).
Differentiating ESCs Recapitulate Yolk Sac
Hematopoiesis
Similar to the embryo, the first hematopoietic cells that
emerge during differentiation of mouse or human ESCs are
primitive erythroblasts with associated macrophages and
megakaryocytes, including a primitive MEP (Fujimoto et al.,
2003; Keller et al., 1993; Klimchenko et al., 2009; Paluru
et al., 2014). Definitive hematopoiesis subsequently emerges,
but it remains unclear whether this represents the in vitro
equivalent of HSC or EMP-derived definitive potential. We
found that ESCs grown as embryoid bodies (EBs) generate a
population of immunophenotypic EMPs coincident with the
emergence of definitive CFCs (Figure 4B). Furthermore, defin-
itive CFCs were predominately associated with the EMP
fraction, while primitive erythroid CFCs did not reside in this
population (Figure 4C). As seen in yolk sacs, macrophage po-
tential of EBs was associated with both primitive and EMP
hematopoiesis. We next asked whether B cell potential
arises independently of EMP during ES/EB differentiation by
comparing EB-derived immunophenotypic EMPs with the
remainder of EB cells that were additionally VE-cadherin pos-
itive (non-EMP VEC+) to enrich for possible B cell potential in
this fraction (Yoshimoto et al., 2011). As in the yolk sac, B cell
potential was distinct from the sorted EMP fraction (Figures 4D
and 4E). Thus, initial emergence of hematopoietic potential
in ES/EBs appears to recapitulate the emergence of HSC-
independent yolk sac hematopoiesis, consisting of a wave of
primitive hematopoiesis followed by the emergence of distinct
populations of EMP-definitive progenitors and a rarer popula-
tion of cells with B cell potential.
EMPs Migrate to the Fetal Liver and Differentiate,
Including Production of Neutrophils
At E10.5, when the liver is colonized with hematopoietic progen-
itors, EMPs were found in most tissues at a similar ratio to
primitive erythroid cells in the peripheral blood, indicating their
widespread presence in the circulation (Figure 5A). EMPs re-
mained enriched in the yolk sac above peripheral blood levels,
as observed at E9.5, but were more highly enriched in the liver
(Figures 1E and 5A). This distribution of immunophenotypic
EMPs mirrors that of functional CFCs in E10.5 embryos (Palis
et al., 1999). Additionally, the numbers of immunophenotypic
EMPs and CFC in E10.5 blood and liver are similar, and day 7
CFC activity was found predominately in sorted EMP (Figure S3).
After E10.5, there is a diminution of circulating EMPs, consistent
with their ingress into the fetal liver, although low numbers of
circulating EMPs are still detected through E14.5, suggesting
they may continue to colonize the fetal liver even as HSCs
expand there (Figure 5B).
Next, we asked whether the extensive in vitro myeloid poten-
tial of EMPs (Figure 3D) is realized in the embryo. Wild-type
females were mated to GFP+ males (UBC-GFP) so the resultant
GFP+ fetal blood cells could be distinguished from any contam-
inating GFP maternal cells. Rare embryonic granulocytes
were detected in circulation as early as E11.5, and by E12.5,
sorted GFP+ myeloid cells included those with neutrophil
morphology (Figures 5C–5E). Myelopoiesis was evident in the
fetal liver by E11.5, with megakaryocytes and macrophages
comprising the majority of the non-erythroid hematopoietic
cells (Figure 5F). While these lineage ratios are consistent
with the in vitro potential of EMPs, early megakaryocytes and
macrophages could also derive from primitive hematopoiesis.
Thus, EMP myeloid fate is best confirmed by the emergence
of granulopoiesis in the murine embryo. The fetal liver con-
tained a similar range of granulocyte intermediates, as defined
by GR-1 staining and cell size, present in the bone marrow (Fig-
ures 5G and 5H), although with higher proportion of immature
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Figure 2. EMPs Are Multipotential Progenitors that Rapidly Proliferate and Differentiate into a Wide Variety of Erythroid-Myeloid Cells
(A) Increases in cell numbers relative to starting numbers in cultures of sorted EMPs or adult lineage-negative kit+ cells (LKs).
(B) Loss of colony-forming ability and accumulation of benzidine-positive cells in the first 4 days of EMP culture.
(C) Morphology of cytospun cells generated by day 4 of maturation cultures of EMPs showing maturing erythroblasts (ery), megakaryocytes (mk), mac-
rophages (m), and occasional neutrophils (n). Cells were stained with Wright’s stain or acetylcholinesterase (ACE) staining (bottom right) for megakar-
yocytes. Scale bar, 25 um.
(D) Morphology of EMP progeny after 7 days. Cytospun cells stained with Wright’s stain or H&E (bottom right). Scale bar, 25 um. n, neutrophil; m, mast;
b, basophil; e, eosinophil; mac, macrophage; ery, erythroblast.
(E) Erythroid, myeloid, and lymphoid gene expression detected by RT-PCR in 7-day EMP and LK cultures. Genes expressed in macrophages (M-CSFR), neu-
trophils (PRTN3), mast cells (mMCP-5,FCεR), basophils (FCεR), megakaryocytes (GP1Bb), erythroblasts (b1-globin), and lymphoid cells (Rag2) are shown.
Representative example of three experiments is shown.
(F) Flow cytometric analysis of cells produced at day 6 of EMP and LK cultures with lineage-specific markers comparing proportions of erythroid (Ter119+) versus
myeloid (CD11b+) and monocyte/macrophage (F4/80+) versus granulocyte (GR-1+) within the CD11b+ fraction. Example of gated populations in Figure S1.
Average of three to five experiments ± SEM. The difference between percent EMP- versus LK-derived cells in each fraction was significant (p < 0.001).
(legend continued on next page)
1896 Cell Reports 11, 1892–1904, June 30, 2015 ª2015 The Authors
forms, as expected for onset and rapid expansion of granulo-
poiesis (Figure 5I). Circulating granulocytes had neutrophil
morphology (Figure 5D, for example), which agrees with a
lack of detectable transcripts in the early fetal liver for eosino-
phil peroxidase (Epx) or a shared surface marker of basophils
and mast cells (FCεR) (Figure 5J). Additionally, consistent
with a neutrophil identity, a significant oxidative burst in fetal
GR-1+ cells was observed after stimulation with bacterial parti-
cles (Figure 5K). These data provide evidence that the broad
granulocyte potential of EMP in vitro is refined in the early fetus
to the output of functional neutrophils.
EMPs Engraft Adult Recipients and Transiently
Generate Red Blood Cells with Adult-like
Characteristics
Given that EMP potential temporally overlaps with that of adult
repopulating HSCs or immature HSCs, (for review, see Frame
(G) E9.5 EMP-derived Emix colony and the cytospun cells within it (below) Scale bars represent 200 mm (top) and 25 mm (bottom).
(H) Lineage combinations present after 6 days of liquid culture of individual E9.5 EMPs. Wells with robust growth (ranging from 10% to 20% of total wells) were
analyzed by flow cytometry (see the Supplemental Information and Figure 1B). All experiments were repeated three to five times to obtain the average ± SEM.
(I) qPCR of transcription factor expression in sorted adult GMPs and MEPs normalized to levels found in sorted EMPs.
Figure 3. E9.5 Yolk Sac B-Lymphoid Poten-
tial Is Not Derived from EMPs
(A) Sorted E9.5 EMPs or bone marrow IL7R+ cells
were cultured for 7 days on OP9 stroma and
examined by flow cytometry for erythroid (Ter119+),
myeloid (CD11b or GR-1+), or B lymphoid
(B220+CD19+) markers.
(B) Quantitation of experiments in (A). n = 3 ± SEM
(C) Potential to differentiate into B cell progenitors
was examined in OP9 stromal co-culture with
removal of non-adherent cells at 5 and 7 days and
analysis at day 10 and 12 for B cells (AA4.1+
CD19+ B220+).
(D) Frequency of cultures that generated lymphoid
progenitors after 12 days. Dissociated total yolk
sac cells or cells with EMP immunophenotype or
the remainder (Non-EMP) were used. ee, embryo
equivalent.
et al., 2013), we asked whether EMPs
contain long-term hematopoietic poten-
tial using UBC-GFP mice as donors to
detect reconstitution of erythrocytes and
platelets as well as myeloid and lymphoid
cells (Schaefer et al., 2001). Long-term
reconstitution was not found when E10.5
EMPswere transplanted into normal adult
recipients or when E9.5 or E10.5 EMPs
were transplanted into immunocompro-
mised mice either by intravenous or by
intrafemoral injection (Figure 6A). In
contrast, E10.5 AGM or adult bone
marrow cells provided long-term multili-
neage reconstitution. Therefore, like early
B cell potential, EMPs are independent of
early HSC potential in the embryo.
However, EMPs did provide varying degrees of short-
term reconstitution (Figure 6A). Transplanted EMPs rapidly
created a wave of circulating RBCs that persisted for weeks
in the adult (Figures 6B and S4). Reconstitution was usually
limited to the erythroid lineage, with only occasional small
numbers of myeloid cells or platelets detected. In the fetus,
EMPs generate larger RBCs that express gamma globin in
embryos transgenic for the human b-globin locus (McGrath
et al., 2011). Interestingly, in the reconstituted adult, EMP-
derived RBCs were instead similar in size to adult RBCs
(Figures 6C and 6D). Additionally, EMPs transgenic for the
human b-globin locus generated RBCs in the adult that
expressed predominately adult b-globin (Figure 6E). Thus, in
the adult hematopoietic environment, EMPs retain their
erythroid-biased short-term hematopoietic potential but
generate mature erythrocytes with adult, rather than fetal,
characteristics.
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DISCUSSION
Thefirst bloodcells inmammalianembryosconsist of largenucle-
ated ‘‘primitive’’ erythroid cells that arise from a transient wave of
yolk sac progenitors. They are replaced in the fetus by smaller,
enucleated red cells that were termed ‘‘definitive’’ more than a
century ago (Maximov, 1909). Fetal and postnatal definitive
RBCswere assumed to comprise one continuous lineagederived
from HSCs. While there is clear evidence that this two-wave
model is an oversimplification, the legacy of this model and its
nomenclature still influences many interpretations of hematopoi-
etic emergence. Primitive hematopoiesis is not restricted to
erythroid cells but is associated with macrophage and megakar-
yocyte potential (Palis et al., 1999; Paluru et al., 2014; Tober et al.,
2007; Hoeffel et al., 2015). Our data have shown further that
primitive and EMP-associated macrophage progenitors can be
distinguished prospectively by immunophenotype. Consistent
with a tri-lineage primitive hematopoietic potential, we and others
have identified populations of maturingmacrophages andmega-
karyocytes in the E9.5 yolk sac prior to formation of the fetal liver
(Tober et al., 2007; Gomez Perdiguero et al., 2015; Hoeffel et al.,
2015). The expression of CD41 and CD45 on these cells compli-
cates theuseof thesemarkers in the identificationof co-emerging
definitive hematopoietic progenitors.
Figure 4. Differentiation of ESCs Generates Temporal Waves of Hematopoiesis Similar to the Yolk Sac
(A) Emergence of a kit+CD41+CD16/32+ population during differentiation of ESCs as embryoid bodies (EBs). Example of day 8 EB from W4 ESC line is shown.
(B) Representative examples of waves of definitive CFC (G-CFC, GM-CFC, BFU-E, or Emix-CFC) or primitive erythroid (EryP-CFC) and immunophenotypic EMPs
during the maturation of two different lines of PC13 ESCs (top) or W4 ESCs (bottom). Values are relative to maximum value seen per 105 EB cells during
maturation.
(C) Distribution of CFC potential, definitive or primitive as defined in (B), as well as Mac-CFC in day 8 EB cells in immunophenotypic EMPs versus the rest of the
cells (Non-EMP). Averages and SEM of four experiments are shown.
(D) Potential of day-9 EB kit+CD41+CD16/32+ cells (EMP) or the VE-cadherin-positive subpopulation of the remaining cells (Non-EMP VEC+) to differentiate into
B cell progenitors after 12 days of co-culture with OP9 stromal cells. Results from a negative culture started with EMPs and a positive culture of non-EMP VEC+
are shown. P13 ESC line was used. B cell potential was not observed in W4 ESC line in parallel experiments, although EMPs were still present.
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It has also become clear that along with the primitive hemato-
poietic potential, definitive blood cells also arise independently
of HSC. In both human and mouse embryos, the first definitive
erythroid progenitors emerge in the yolk sac before HSCs arise
and colonize the fetal liver prior to HSCs (for review, see Frame
et al., 2013). Although kit and CD41 mark both EMP and HSC
Figure 5. EMPs Migrate to the Fetal Liver and Differentiate, Including Generation of Mature Neutrophils
(A) Enrichment of EMPs in E10.5 tissues relative to circulating primitive erythroid cells (EryP). n = 3 or 4 ± SEM. *p < 0.01, **p < 0.003
(B) Numbers of circulating immunophenotypic EMPs per embryo by flow cytometry. n = 3 ± SEM.
(C) Examples of imaging flow cytometry of peripheral blood from GFP+ E11.5 embryos. A nucleated primitive erythroblast is at the top of the images and the cell
indicated by an asterisk is an embryonic granulocyte. Scale bar, 10 mm.
(D) Images of cytospun GFP+ Ter119 cells from E12.5 blood. Scale bar, 25 mm.
(E) Numbers of erythroid cells (Ter119+), macrophages (CD11b+F4/80+) and granulocytes (CD11b+ GR-1+) per embryo in circulation. Results from 3 to 5 ex-
periments ± SEM.
(F) Numbers of erythroid cells, monocyte/macrophages and granulocytes per fetal liver were identified as in (E). Megakaryocytes (Mk) were identified as kit
CD41+ with similar light scatter values as the other cells (to eliminate platelets). Results from three to five experiments ±SEM.
(G) Analysis of granulocytes in bone marrow divided into early, mid, and late maturational stages based on cell size and the median pixel value for GR-1.
Scale bar, 10 mm.
(H) Images of maturing granulocytes from E12.5 liver. Scale bar, 10 mm.
(I) Proportion of granulocytes in maturational stages as in (G). n = 3 ± SEM.
(J) Expression of eosinophil (eosinophil peroxidase, Epx) or basophil and mast cell (FCεR1) transcripts as determined by RT-PCR in fetal liver samples and
bone marrow.
(K) Analysis of oxidative burst in adult and E13.5 peripheral blood granulocytes after simulation with bacteria-like particles. Significance of induction in fetal p < 104.
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emergence (Bertrand et al., 2005; Ferkowicz et al., 2003; Mikkola
et al., 2003; Mitjavila-Garcia et al., 2002), we find that EMPs
also become CD16/32+, a triple-positive immunophenotype
without corollary in the adult hematopoietic hierarchy (Miyawaki
et al., 2015; Pronk et al., 2007). This phenotype made it possible
to trace EMP emergence in the E8.5–E9.5 yolk sac and their
colonization of the fetal liver at E10.5–E11.5. In contrast to the
small numbers of adult transplantable and/or immature HSCs
detected per embryo until E12.5, thousands of EMPs and
hundreds of thousands of hematopoietic intermediates are de-
tected during this time. These data complement lineage-tracing
experiments demonstrating yolk sac progenitors contribute
significantly to fetal liver myelopoiesis (Gomez Perdiguero
et al., 2015; Hoeffel et al., 2015). Although mouse embryos
defective in HSC formation survive until birth, embryos with de-
fects in primitive erythropoiesis die as early as E9.5, and those
with defects in EMP-derived definitive erythropoiesis die by
E15.5 (Chen et al., 2011; Fujiwara et al., 1996; Mucenski et al.,
1991). Thus, the yolk sac provides erythroid andmyeloid function
through two distinct waves of progenitors that sequentially sup-
port embryogenesis until HSC-derived hematopoiesis is estab-
lished at later stages of gestation.
EMPs generate erythroid cells, megakaryocytes, and a wide
range of myeloid lineages in vitro. Our clonal analyses confirmed
the presence of single EMPs with erythroid and myeloid
potential, consistent with ‘‘common myeloid progenitors’’
(CMPs). However, there are important distinctions between
EMPs and adult CMPs. In the adult, CD16/32 is expressed at
low levels in CMPs and high levels in GMPs, which have lost
erythroid and megakaryocyte potential (Akashi et al., 2000).
Furthermore, adult murine CMPs can be subfractionated into a
CD150+ population with mainly MEP potential and a CD150
Figure 6. EMPs Engraft Adult Recipients and Provide Transient Erythroid Reconstitution
(A) Frequency of micewith short-term (<8weeks) and long-term reconstitution (>16weeks) of blood cells after transplantationwith sorted embryonic cells or bone
marrow linkit+sca+ (LSK) into wild-type or NSG recipients.
(B) Example of erythroid reconstitution after injection of 4,500 E9.5 or 6,000 E10.5 sorted EMPs or 200 bone marrow LSKs.
(C) Representative images of EMP-derived circulating definitive erythroid cells (E11.5 RBC-def) isolated from E11.5 blood, and EMP-derived RBCs generated in
an adult recipient and as well as recipient’s endogenous RBCs. Scale bar, 10 mm.
(D) Diameter of RBCs as measured by imaging flow cytometry (height of Ter119 morphology mask). Average of three experiments is shown ± SEM.
(E) Expression of human b-globin genes in transgenic EMP-derived cells transplanted into non-transgenic recipients (EMP Transplant) plotted as percent of total
human b-globin message detected. Expression levels from tissues in transgenic mice are shown for comparison: primitive erythroblasts from peripheral blood
(E11.5 Ery-Prim) and EMP-derived erythroid cells sorted from E11.5 livers (E11.5 FL-Def) to remove circulating primitive erythrocytes (McGrath et al., 2011) aswell
as adult RBCs. Average of three samples ± SEM is shown.
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population with mainly GMP potential (Pronk et al., 2007). In
contrast, EMPs express high levels of CD16/32 and lack
CD150 expression yet are still strongly biased to generate
erythroid cells and megakaryocytes. In vitro, EMPs are also
biased to produce more macrophages than granulocytes, while
CMPs preferentially form granulocytes (Akashi et al., 2000).
These in vitro lineage biases are consistent with their expression
profile of transcription factors known to control adult erythro-
myeloid lineage choice. This suggests that EMPs not only
make definitive, or adult-like, blood cells but also may share
transcriptional regulators with adult hematopoiesis in altered
proportions that generate a hematopoietic progenitor specif-
ically designed to meet the needs of the rapidly growing embryo.
Primitive hematopoietic progenitors and EMPs each generate
megakaryocytes andmacrophages. It has recently been demon-
strated that yolk sac progenitors are an important source of mul-
tiple tissue-residentmacrophages in the adult. Both primitive and
EMP-derived macrophages have been traced to different adult
tissues. (Kierdorf et al., 2013; Gomez Perdiguero et al., 2015;
Schulz et al., 2012; Ginhoux et al., 2010; Hoeffel et al., 2015).
The first definitive erythroid and granulocyte potential in the
mouse embryo is derived from EMPs and not from primitive
hematopoiesis, and thus we used these lineages to specifically
analyze EMP differentiation. Our previous studies demonstrated
expanding definitive erythropoiesis in the fetal liver and the first
definitive erythrocytes in the circulation by E11.5 (McGrath
et al., 2011). Similarly, we report here that fetal granulocytes are
present in the liver and bloodstream by E11.5 and then expand
rapidly in both compartments. Interestingly, the wider granulo-
cytic potential of EMPs is apparently narrowed to a neutrophil
fate in the early fetus. Although we do not yet know if neutrophils
have a role in mammalian embryogenesis, fetal neutrophils ex-
hibited antibacterial oxidation responses consistent with a role
in host defense. There are also possible roles for neutrophils in
angiogenesis and niche interactions as seen in the adult (Casa-
nova-Acebes et al., 2014; Christoffersson et al., 2012).
The emergence of lymphoid or long-term hematopoietic po-
tential temporally overlaps with EMP emergence (Godin et al.,
1995; Kieusseian et al., 2012; Kumaravelu et al., 2002; Yoder
et al., 1997; Yoshimoto et al., 2011, 2012). While it is unclear
how these latter potentials relate to one another, they have char-
acteristics distinct from EMPs. Both lymphoid and nascent HSC
emergences aremore broadly distributed and considerablymore
rare than EMPs. However, the overlap in markers and timing
could indicate they comprise a subset of EMPs. Our analysis of
purified populations of EMPs demonstrated that early lymphoid
and HSC potential are indeed distinct at E9.5. Taken together,
these data indicate that the emergence of hematopoiesis in the
embryo is remarkably complex, with distinct hematopoietic
populations that have varied spatio-temporal emergence, abun-
dance, lineage potential and persistence. It is important to note
that our studies have focused on the onset of hematopoiesis
and prior to significant HSC expansion, so they do not rule out
the possibility that hematopoietic progenitors continue to evolve
in their phenotype or potential over time.
Ultimately, it will be important to determine how hematopoietic
stem and progenitor cells with different lineage restrictions and
self-renewal potential are generated in the developing embryo.
ESCs and induced pluripotent stem cells (iPSCs) are important
experimental models of hematopoietic emergence with the
promise of serving as a source of cell-based therapies. However,
the absence of precise temporal and spatial cues makes it diffi-
cult to correlate findings in the ESC/iPSC system with those
known to occur in the embryo. By comparing our observations
in the embryo directly with those from differentiating ESCs, we
found that ESCs recapitulated the hematopoietic development
present in the yolk sac, including primitive hematopoietic, defin-
itive EMP, and rare B cell potential. This is not unexpected, given
that these models mimic early embryogenesis and hematopoie-
sis generated from yolk sac progenitors account for almost all of
the blood cells seen in the murine embryo from E7.5 to E12.5.
The ability to identify and track yolk-sac-derived hematopoietic
lineages should facilitate future studies directing the develop-
ment of ESC/iPSC systems beyond the yolk sac phase of
hematopoietic emergence toward the formation of HSCs.
Additionally, given their potential to provide short-term definitive
erythrocytes, platelets, and granulocytes, EMPs might also
serve therapeutic roles. A better understanding of EMPs will be
critical to increase the cellular output and compatibility with the
adult hematopoietic microenvironment.
EXPERIMENTAL PROCEDURES
Mice, Tissue Collection, and Processing
Mice were used in accordance with the guidelines of the University of Roches-
ter School of Medicine and Dentistry institutional animal care and use commit-
tee. Mice were maintained on 12-hr dark and light cycles. See Supplemental
Experimental Procedures for strains used. Mice were mated overnight and
vaginal plugs examined in themorning (E0.3). Micewere sacrificed byCO2 nar-
cosis. Embryonic tissues were isolated from staged embryos and dissociated
as previously described (McGrath et al., 2011). Adult peripheral blood was
collected from a tail or submandibular vein for analysis of reconstitution or
from the descending vena cava for terminal analysis. Femoral marrow was
flushed and dissociated by trituration. For transplantation, cells were injected
either in the tail vein or intrafemorally (Schmitz et al., 2011) into recipients pre-
conditioned with 5-Gy total body irradiation (TBI) for C57B6 and 1.5-Gy TBI for
non-obese diabetic scid gamma (NSG) mice.
In Vitro Cultures
Colony-forming assays for megakaryocyte progenitors, erythroid and myeloid
progenitors, and high-proliferative-potential progenitors were performed as
previously described (Palis et al., 2001; Palis and Koniski, 2005). Embryonic
tissues were explanted with two embryo equivalents in 100 ml media as
described previously (Shah et al., 2013). Sorted cells were cultured in matura-
tion media (Arinobu et al., 2005) containing 20 ng/ml murine stem cell factor,
interleukin-3 (IL-3), IL-6, and IL-7, 50 ng/ml IL-5 and IL-9, 10 ng/ml IL-11, gran-
ulocyte-macrophage colony-stimulating factor and thrombopoietin, (all Pepro-
tech), and 2U/ml erythropoietin (Amgen) at 105 cells/ml or less. Short-term and
long-term assays of B cell progenitors were performed as described previ-
ously (Yoshimoto et al., 2011).
ESC/EB Cells
PC13 ESCs (University of Rochester Transgenic Facility) and W4 cell lines
(developed in the laboratory of Dr. Alex Joyner at NYU School of Medicine)
were cultured as EBs essentially as described previously (England et al.,
2011), except that EBs were dissociated using collagenase type 1 according
to the manufacturer’s instructions (STEMCELL Technologies).
Cell Staining and Microscopy
Cytospun cells were stained using an automated Wright stain (Sigma) as
described previously (Kingsley et al., 2004) or stained with standard H&E or
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acetylcholinesterase (ACE). Photomicroscopy was performed on a Nikon
Eclipse 80i microscope using a 1003 objective or, for colonies, a Nikon
TE2000 and a 203 objective. Images were captured with a Nikon DS-Fi1
camera and minimally processed using Nikon Elements AR or Photoshop
software.
PCR
For RT-PCR, RNA was extracted using RNeasy Plus Mini Kits (QIAGEN) and
cDNA synthesized utilizing SuperScript First-Strand Synthesis Systems (Invi-
trogen) according to the manufacturer’s instructions. For qRT-PCR, cDNA
wasmade from sorted cells using the Cells to CT kit according to themanufac-
turer’s instructions (ABI). Primers and conditions are contained in the Supple-
mental Experimental Procedures. Expression levels were normalized to 18S
transcript levels.
Flow Cytometry and Cell Sorting
Cells were blocked with 10%normal rat serum (Invitrogen) and then stained as
indicated in the Supplemental Experimental Procedures with 1:100 dilutions of
antibodies, vital DNA stain (10 mM DRAQ5 (eBioscience), or Vibrant Violet as
recommended (Invitrogen) and live/dead discriminator (1 mg/ml propidium
iodide or 5 mg/ml DAPI; Invitrogen). Engraftment of RBCs and platelets was
assayed using 2 ml whole blood, and engraftment of myeloid cells was deter-
mined using 50 ml blood analyzed after RBC lysis. Oxidative burst assay was
performed after stimulation of cells with S. aureus bioparticles (Life Technolo-
gies) and detected utilizing dihydroethidium (DHE; Sigma) as reported previ-
ously (McFarlin et al., 2013). Cells were sorted using a FACS Aria or analyzed
on an LSRII (BD Bioscience) using FlowJo analysis software (Tree Star).
Imaging flow cytometric data were collected on a ImageStreamX and analyzed
using IDEAS 6.0 (Amnis).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.05.036.
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